MIRA Knowledge Exchange Plenary 1: Aging, senescence, senolytics and immunity by Dr. James Kirkland

Dr. James Kirkland
Noaber Foundation Professor of Aging Research, Mayo Clinic;
Principal Investigator, NIH Translational Geroscience Network;
President, American Federation for Aging Research

[@samatoid]

I am happily surprised all these trials are going on especially for readily available senolytics like quercetin and fisetin. Also excited about the rapalogs. So much was presented here.